COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,652 Articles (22,913 medRxiv, 8,739 bioRxiv)

Most recent first Previous |  Page 290: Articles 2891-2900  | Next

Prospective Clinical Surveillance for Severe Acute Respiratory Illness in Kenyan Hospitals during the COVID-19 pandemic
Lucinde, R. K., Gathuri, H., Isaaka, L., Ogero, M., Mumelo, L., Kimego, D., Mbevi, G., Wanyama, C. W., Otieno, E. O., Mwakio, S., Saisi, M., Isinde, E., Oginga, I. N., Wachira, A., Manuthu, E., Kariuki, H., Nyikuli, J., Wekesa, C., Otedo, A., Bosire, H., Okoth, S. B., Ongalo, W., Mukabi, D., Lusamba, W., Muthui, B., Adembesa, I., Mithi, C. W., Sood, M., Aliyan, N., Gituma, B., Giabe, M., Omondi, C., Aman, R., Amoth, P., Kasera, K., Were, F., Nganga, W., Berkley, J. A., Tsofa, B. A., Mwangangi, J., Bejon, P., Barasa, E., English, M., Scott, J. A. G., Akech, S., Kagucia, E. W., Agweyu, A., Etyan
10.1101/2024.03.03.24303690 — Posted: 2024-03-04
Enhancing COVID-19 Case Forecasting in the United States: A Comparative Analysis of ARIMA, SARIMA, and RNN Models with Grid Search Optimization
Abolmaali, S., Nichols, S.
10.1101/2024.03.04.24303713 — Posted: 2024-03-04
Redeployment Experiences of Healthcare Workers in the UK during COVID-19: data from the nationwide UK-REACH study
Zuzer Lal, Z., Martin, C. A., Gogoi, M., Qureshi, I., Bryant, L., Papineni, P., Lagrata, S., Nellums, L. B., Al-Oraibi, A. S., Chaloner, J., Woolf, K., Pareek, M.
10.1101/2024.03.03.24303615 — Posted: 2024-03-04
Determining the feasibility of linked claims and vaccination data for a Covid-vaccine pharmaco-epidemiological study in Germany - RiCO feasibility study protocol
Timmesfeld, N., Ihle, P., Denz, R., Meiszl, K., Scholz, K., Oberle, D., Drechsel-Baeuerle, U., Keller-Stanislawski, B., Diebner, H. H., Meyer, I.
10.1101/2024.03.04.24303714 — Posted: 2024-03-04
Modelling long COVID using Bayesian networks
Perez Chacon, G., Mascaro, S., Estcourt, M. J., Phetsouphanh, C., Nicholson, A. E., Snelling, T., Wu, Y.
10.1101/2024.03.04.24303715 — Posted: 2024-03-04
Genome-wide association study between SARS-CoV-2 single nucleotide polymorphisms and virus copies during infections
Li, K., Chaguza, C., Chew, Y. T., Chen, N. F. G., Ferguson, D., Pandya, S., Kerantzas, N., Schulz, W., Yale SARS-CoV-2 Genomic Surveillance Initiative, , Hahn, A. M., Pitzer, V. E., Weinberger, D. M., Grubaugh, N. D.
10.1101/2024.03.02.24303655 — Posted: 2024-03-04
The seroprevalence of SARS-CoV-2-specific antibodies in Australian children: a cross sectional study
Koirala, A., McRae, J., Britton, P. N., Downes, M., Prasad, S. A., Nicholson, S., Winkler, N. E., O'Sullivan, M., Gondalwala, F., Castellano, C., Carey, E., Hendry, A., Crawford, N., Wadia, U. D., Richmond, P., Marshall, H. S., Clark, J. E., Francis, J. R., Carr, J., Bartlett, A., McMullan, B., Skowno, J., Hannah, D., Davidson, A., von Ungern-Sternbeg, B. S., Lee-Archer, P., Burgoyne, L. L.-a., Waugh, E. B., Carlin, J. B., Naing, Z., Kerly, N., McMinn, A., Hunter, G., Heath, C., D'Angelo, N., Finucane, C., Francis, L. A., Dougherty, S., Rawlinson, W., Karapanagiotidis, T., Cain, N., Brizuela
10.1101/2024.03.03.24303672 — Posted: 2024-03-04
Engineering customized viral receptors for various coronaviruses
Liu, P., Huang, M., Guo, H., Si, J., Chen, Y., Wang, C., Yu, X., Shi, L., Xiong, Q., Ma, C., Tong, F., Liu, C., Chen, J., Guo, M., Li, J., Shi, Z.-L., Yan, H.
10.1101/2024.03.03.583237 — Posted: 2024-03-04
Immunogenicity and safety of a live-attenuated SARS-CoV-2 vaccine candidate based on multiple attenuation mechanisms
Suzuki, M., Okamura, S., Gis, T., Sasaki, H., Lee, S., Yoshida, A., Goto, S., Nakagawa, T., Ikawa, M., Kamitani, W., Takekawa, S., Yamanishi, K., Ebina, H.
10.1101/2024.03.03.582873 — Posted: 2024-03-04
Heterogeneous hybrid immunity against Omicron variant JN.1 at 11 months following breakthrough infection
He, X., Jiang, J., Li, G., Liu, J., Gan, J., Zhou, L., Bai, C., Zi, Q., Mou, X., Zeng, S., Yuan, J., Zhou, C., Li, Y., Zhu, G., Zhao, R., Yang, L., Wu, J., Zhang, H., Xian, J., Wang, Z., Qi, Q., Liu, Y., Yu, J., Liu, D., Li, W.
10.1101/2024.03.02.583082 — Posted: 2024-03-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).